<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-111423</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Amphicrine tumor of gastric antrum&#151;A case rport</dc:title>
<dc:description xml:lang="en">Malignant amphicrine tumors are a group of tumors in which tumor cells show evidence of both epithelial as well as neuroendocrine differentiation. Malignant amphicrine tumors of gastric region though have been reported are not very common. Histopathological examination of these tumors show features of adenocarcinoma or grade 1 to 2 neuroendocrine tumor. Immunohistochemically, these tumors are positive for both neuroendocrine as well as epithelial markers indicating their amphicrine nature. Malignant amphicrine tumors are now classified as a new subgroup based on WHO classification. The rarity of this tumor in gastric antrum made us to report the case(AU)</dc:description>
<dc:creator>Chawla, Nitin</dc:creator>
<dc:creator>Agrawal, Mukesh</dc:creator>
<dc:creator>Jaibhaskar Reddy, Sangireddy</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los tumores anficrinos malignos son un grupo de tumores en los que las células tumorales muestran evidencia de diferenciación tanto epitelial como neuroendocrina. Los tumores anficrinos malignos de estómago aunque han sido reportados no son muy comunes. El examen histopatológico de los tumores muestra características de adenocarcinoma o tumor neuroendocrino grado 1 a 2. Mediante inmunohistoquímica, estos tumores son positivos para ambos, marcadores neuroendocrinos así como marcadores epiteliales, indicando su naturaleza anficrina. Los tumores anficrinos malignos se clasifican ahora como un nuevo subgrupo en clasificación de la OMS. La rareza de este tumor en el antro gástrico nos motivó a publicarlo(AU)</dc:description>
<dc:source>Rev. esp. patol;46(2): 79-82, abr.-jun.2013. ilus, tab</dc:source>
<dc:identifier>ibc-111423</dc:identifier>
<dc:title xml:lang="es">Tumor anficrino de antro gástrico-comunicación de un caso</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d238^s22053</dc:subject>
<dc:subject>^d22921^s22066</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5911^s22053</dc:subject>
<dc:subject>^d12141^s22053</dc:subject>
<dc:subject>^d22921^s22074</dc:subject>
<dc:subject>^d31587^s22053</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
